课题基金 / 基金详情

项目摘要

项目成果

Kenneth L Pitter的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Glioblastoma multiforme (GBM) is the most aggressive and most common malignant glioma with an average overall survival is only 14.6 months. Despite aggressive therapy consisting of surgical resection, ionizing radiation, and both concurrent and maintenance chemotherapy, the disease ultimately recurs. The exact cellular and molecular mechanisms that allow these gliomas to recur remains an area of intense research, but recent evidence suggest that gliomas have a relatively small population of stem-like cells that are resistant to irradiation and chemotherapy. We have observed primary glioma cultures take on a more stem-like and aggressive phenotype when co-cultured with temozolomide, and herein propose to evaluate these this phenomena in vivo. For this purpose, we will treat murine gliomas with either radiation and/or chemotherapy, and characterize their stem- like properties upon recurrence. I plan to develop a mouse model of recurrent GBM using a genetically engineered mouse model (GEMM) of PDGF-driven glioma generated by the RCAS-tva system. Aberrant PDGF signaling is seen in approximately 30% of human GBMs, and the murine gliomas generated with this system closely resemble both the pathology and genetic characteristics the human disease. Both primary and recurrent murine gliomas will be will be compared using a variety of assays to characterize their functional stem-like properties. Specifically, the gliomas will be compared using tumorsphere formation assays, and by examining the expression of stem-like markers with immunohistochemistry and immunofluorescence. Primary and recurrent gliomas will also be compared quantitatively by examining stem-like markers using western blot analysis and quantitative real time PCR, by performing side population analysis, and by assaying orthotopic tumor forming ability. Additionally, primary and recurrent gliomas will be compared to assess any differences in the activation of signaling pathways that are well known to convey a stem-like phenotype, such as the Notch and PI3K/AKT pathway. Together, these experiments will characterize the functional stem-like properties of recurrent gliomas, and explore the pathways that may confer this phenotype. )
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Cellular phenotypic heterogeneity and resistance to radiotherapy in pancreatic adenocarcinoma
  • 批准号:
    10254822
  • 项目类别:
  • 资助金额:
    $39.38万
  • 财政年份:
    2021
  • 负责人:
    Kenneth L Pitter
  • 依托单位:
Cellular phenotypic heterogeneity and resistance to radiotherapy in pancreatic adenocarcinoma
  • 批准号:
    10693293
  • 项目类别:
  • 资助金额:
    $39.38万
  • 财政年份:
    2021
  • 负责人:
    Kenneth L Pitter
  • 依托单位:
Characterizing the functional stem-like properties of primary and recurrent gliom
Characterizing the functional stem-like properties of primary and recurrent gliom
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
  • 批准号:
    2021JJ40433
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2021
  • 负责人:
    孙磊
  • 依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
  • 批准号:
    32001603
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    24.0万元
  • 批准年份:
    2020
  • 负责人:
    段真珍
  • 依托单位:
AREA国际经济模型的移植.改进和应用
  • 批准号:
    18870435
  • 项目类别:
    面上项目
  • 资助金额:
    2.0万元
  • 批准年份:
    1988
  • 负责人:
    史树中
  • 依托单位: